Pfizer to abandon $160 billion merger with Allergan
The move follows a crackdown by the US government on corporate inversions
Pfizer decided to terminate its $160 billion (€140 billion) merger with Allergan, a person familiar with the matter said, marking an end to the largest-ever health-care acquisition as officials in Washington crack down on corporate inversions.
Pfizer will need to pay a $400 million fee to Allergan for expenses relating to the deal, the person said, asking not to be identified as the information is private. Allergan, which is run from New Jersey but has...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Housing crisis is coming home to roost for the government parties
Last week’s debacle – where almost an entire housing estate intended for first-time buyers was snapped up by an investment firm – could spark a disaster for the parties who maintain the status quo
Matt Cooper: Falling house of cards could take this government with it
The housing crisis hasn’t gone away, you know. It was only a matter of time until the fund-warped development model came back to bite those currently in power
Colin Murphy: Unionists are not the only ones ensnared by figments of the past
There is a long and pernicious assumption that unionists just need to realise that they are actually Irish and that a united Ireland will then fall into place
Willie O’Reilly: Pressing home the point that truth is not a luxury
As guardians of values such as integrity, newspapers have a role to play in stopping the rot that is the eroding of trust on social media and virtual channels